These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2932060)

  • 21. [Clinical trial of 5'-DFUR against various malignant tumors].
    Okumura T
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2365-70. PubMed ID: 2934025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination phase II study of weekly paclitaxel and 5'-DFUR for unresectable or recurrent gastric cancer.
    Yoshino S; Furuya T; Shimizu R; Ozasa H; Nishimura T; Fukuda S; Kawaoka T; Hazama S; Oka M
    Anticancer Res; 2013 Jun; 33(6):2629-33. PubMed ID: 23749919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical phase II study of 5'-DFUR for cancer of the digestive organs by a cooperative study group].
    Urushizaki I; Kogo Y; Kouda K; Ishitani K; Niitsu Y; Matsuda M; Gocho Y; Koyama R; Nagai T; Saijo N
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2358-64. PubMed ID: 3000300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy of long-term oral chemotherapy with 5'-deoxy-5-fluorouridine and cyclophosphamide for recurrent breast cancer.
    Iba T; Kidokoro A; Fukunaga M; Sugiyama K; Aihara N; Suda M
    Int J Clin Oncol; 2004 Oct; 9(5):383-7. PubMed ID: 15549589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [5'-DFUR chemoprophylaxis in superficial bladder cancer. Kanagawa Urology 5'-DFUR Study Group].
    Kubota Y; Noguchi S; Masuda M; Hosaka M; Noguchi K; Sasaki K; Miura T; Ikeda I; Kondo I; Senga Y; Moriyama M; Fukushima S; Ebato T; Fukuda M; Kitami K; Fukuoka H; Sato K; Hirokawa M; Chiba K; Kanno H; Miyai K
    Hinyokika Kiyo; 2000 Aug; 46(8):525-30. PubMed ID: 11019370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A comparative study with 5'-DFUR alone or in combination with tamoxifen (TAM) or medroxyprogesterone acetate (MPA) for advanced or recurrent breast cancer].
    Takatsuka Y; Yayoi E; Miyauchi K; Aikawa T; Maeura Y; Hirai T; Kotsuma Y
    Gan To Kagaku Ryoho; 1992 May; 19(5):631-6. PubMed ID: 1533755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Phase II study of 5'-DFUR in uterine cervical cancer and ovarian cancer].
    Noda K; Ikeda M; Saito Y; Yajima A; Sato A; Suzuki M; Terashima Y; Ochiai K; Yoshida K; Takada M
    Gan To Kagaku Ryoho; 1991 Dec; 18(15):2557-65. PubMed ID: 1660700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [5-FU concentrations in the blood and tumor tissue after 5'-DFUR or UFT administration in the patients with uterine cervical cancer].
    Suzuki M; Aida I; Ohwada M; Sato I; Tamura T; Kasuga Y
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):253-8. PubMed ID: 7857101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Randomized comparison of continuous and intermittent oral administration of 5'-deoxy-5-fluorouridine in the treatment of advanced gastric cancer; a phase II trial by the Multi-institutional Cooperative Study Group].
    Niitani H; Kurihara M; Hasegawa K; Hatta Y; Suwa T; Tsuboi E; Yasui A; Yoshimori K; Kawachi M; Taguchi S
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3345-50. PubMed ID: 2961307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Combination therapy of high dose 5'-DFUR+MMC for advanced or recurrent gastric cancer. 5'-DFUR Joint Research Group in the Osaka District for Gastric Cancer].
    Nakata E; Okajima K; Ishida Y; Munetomo Y; Gotoh K; Toyohara M; Miyazaki H; Matsunaga S; Maeura Y; Fujimura T
    Gan To Kagaku Ryoho; 1995 Oct; 22(12):1799-806. PubMed ID: 7574813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A phase I study of docetaxel (TXT) and doxifluridine (5'-DFUR) combination therapy in patients with advanced and recurrent breast cancer].
    Tominaga T; Nishimura R; Aoyama H; Iwase H; Mitsuyama S; Asaga T; Kimura M;
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):965-72. PubMed ID: 11478146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A randomized controlled study of maintenance therapy with (2"R)-4'-O-tetrahydropyranyladriamycin for advanced and recurrent breast cancer. Clinical Study Group of THP for Breast Cancer in Japan].
    Enomoto K; Tominaga T; Abe R; Iino Y; Koyama H; Nomura Y; Abe O; Nakazato H
    Gan To Kagaku Ryoho; 1996 Jun; 23(7):871-80. PubMed ID: 8678535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of recurrent esophageal cancer maintaining complete long-term response after 5'-DFUR and ftorafur administrations].
    Mizuno Y; Makino N; Matsumoto K; Fujimura N; Yamamoto E; Ishida C; Koyama S; Naitoh M; Maezato K; Matsukawa Y
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):533-6. PubMed ID: 1532707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative studies on the antitumor activity of the fluorinated pyrimidines 5'-DFUR, tegafur, UFT and FUra on various murine tumors].
    Miwa M; Eda H; Fukuda H; Fujimoto K; Ishitsuka H
    Gan To Kagaku Ryoho; 1988 May; 15(5):1755-63. PubMed ID: 2967051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient].
    Toi M; Taniguchi T; Hayashi K; Tominaga T
    Gan To Kagaku Ryoho; 1995 May; 22(6):799-804. PubMed ID: 7755388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Successful treatment of disseminated breast cancer with combination therapy of 5'-deoxy-5'-fluorouridine (5'-DFUR), medroxyprogesterone acetate (MPA) and cyclophosphamide (CPA)].
    Takatsuka Y; Katoh T; Tsumura I; Kobayakawa K; Kawahara T
    Gan To Kagaku Ryoho; 1992 Jan; 19(1):107-10. PubMed ID: 1530905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Combination therapy of high dose doxifluridine (5'-DFUR)+mitomycin C (MMC) for advanced or recurrent colorectal cancer. Joint Research Group in the Osaka Area for Combination Therapy of 5'-DFUR with Other Drugs].
    Kikkawa N; Taguchi T; Sakai K; Irie K; Terasawa T; Shimoyama T; Iwanaga T; Fukuda I; Okumura S; Yasutake K
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):117-23. PubMed ID: 8422175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [An early phase II clinical study of S-1 in patients with breast cancer. S-1 Cooperative Study Group (Breast Cancer Working Group)].
    Taguchi T; Morimoto K; Horikoshi N; Takashima S; Toge T; Kimura M; Sano M; Aoyama H; Ota J; Noguchi S
    Gan To Kagaku Ryoho; 1998 Jun; 25(7):1035-43. PubMed ID: 9644319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II trial of UFT activity in pretreated breast cancer patients.
    Daniels M; Díaz-Rubio E; Guillem V; Montero JM; García-Conde J; Estapé J; Martín M; Herranz C; Ordoñez A; Galán A
    Jpn J Clin Oncol; 1993 Dec; 23(6):363-5. PubMed ID: 8283790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Investigation of 5-fluorouracil (5-FU) levels and pyrimidine nucleoside phosphorylase activities in the tissues from patients with uterine cervical and ovarian cancers after oral administration of 5'-DFUR].
    Noda K; Watanabe Y; Ikeda M; Takeuchi K; Hasegawa K; Kinugasa M; Sekiba K; Kobashi Y; Ohiwa T; Odagiri H
    Gan To Kagaku Ryoho; 1991 Dec; 18(15):2551-5. PubMed ID: 1836128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.